Bupropion as an Augmenting Agent in Patients of Depression with Partial Response

Basic and Clinical Pharmacology and Toxicology

Volumn 110, Issue 3, 2012, Pages 227-230

  Gulrez, Gaurav ^a   Badyal, Dinesh Kumar ^a   Deswal, Randhir Singh ^a   Sharma, Arvind ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; ESCITALOPRAM; PAROXETINE; SERTRALINE;

ADD ON THERAPY; ADULT; AMRITSAR DEPRESSIVE INVENTORY; ANOREXIA; ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFECT; DRUG RESPONSE; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; INSOMNIA; LOOSE FECES; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84857366978     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00788.x     Document Type: Article

References (19)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental disorder, 4th edn. American Psychiatric Association, Washington DC, 2000.
2. Mann JJ. Drug therapy: the medical management of depression. N Engl J Med 2005;353:1819-18.
3. Poongothai S, Pradeepa R, Ganesan A, Mohan V. Prevalence of depression in a large urban South Indian population - The Chennai urban rural epidemiology study (CURES - 70). PLoS ONE 2009;4:7185.
4. Esposito E. Serotonin-Dopamine Interaction as a focus of novel antidepressant drugs. Curr Drug Targets 2006;7:177-85.
5. Simon GE, Khandker RK, Ichikawa L, Operskalski BH. Recovery from depression predicts lower health services costs. J Clin Psychiatry 2006;67:1226-31.
6. Lam RW, Kennedy SH, Parikh SV. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. J Affect Disord 2009;117:26-43.
7. De Battista C. Augmentation and combination strategies for depression. J Psychopharmacol 2006;20:11-8.
8. Thase ME. Therapeutic alternative for difficult to treat depression: a narrative review of the state of evidences. CNS specter 2004;9:808-21.
9. Trivedi MH, Fava M, Rush AJ. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006;354:1243-52.
10. De Battista C, Doghraniji K, Menza MA, Rosenthal MH, Fieve RR. Adjunct modafinil for the short term treatment of fatigue and sleepiness in patients with major depressive disorders: a preliminary double-blind, placebo-controlled study. J Clin Psychiatry 2003;64:1057-64.
11. Bergman J, Miodownik C, Palatnik A, Lerner V. Efficacy of bupropion XR in treatment-resistant elderly patients: a case series study. J Clin Neuropharmacology 2011;34:17-20.
12. Augsburg B. Augmentation strategies for therapy resistant depression. J Clin Pharm Ther 2007;34:165-74.
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
14. Montgomery SA, Asberg MC. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.
15. Nierenberg AA. Do some antidepressants work faster then others? J Clin Psychiatry 2001;62(Suppl. 15):22-5.
16. Singh G. A new depressive inventory (Amritsar Depressive Inventory). Indian J Psychiatry 1974;16:183-8.
17. Kennedy SH, McCann SM, Masellis M. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. J Clin Psychiatry 2002;63:181-6.
18. Swenson JR, O'Connors CM, Barton D. Influence of depression and effect of treatment with sertraline on quality of life hospitalization for acute coronary syndrome. Am J Cardiol 2003;92:1271-6.
19. Rocca P, Calvarese P, Faggiano F, Marchiaro L, Mathis F, Rivoira E et al. Citalopram versus sertraline in late life non major clinically significant depression a 1year follow up clinical trial. J Clin Psychiatry 2005;66:360-5.